Retinitis PigmentosaRare disease
What this study is
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision.
The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment.
The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
Study details
- Official title
- Observational, Non-Interventional Study to Determine the Operational Feasibility and Measurement Properties of Endpoints in Patients with Retinal Degeneration
- Sponsor
- Ray Therapeutics, Inc.
- Conditions
- Retinitis Pigmentosa · Choroideremia · Stargardt Macular Dystrophy · Stargardt Disease · Geographic Atrophy from Age-related Macular Degeneration · X-lined Retinoschisis · Retinal Dystrophies
- Enrolling
- 120 people
- Starts
- 2024-04-05
- Est. completion
- 2026-04-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Diagnosis of bilateral retinitis pigmentosa, choroideremia, Stargardt macular dystrophy, geographic atrophy from age-related macular degeneration, X-linked retinoschisis or other retinal dystrophies confirmed from previous eye examination records
- Best-corrected visual acuity between 20/70 and HM in at least one eye as tested with clinic-based visual acuity method
- Reasonably fluent in English
You can't join if
- Cognitive impairment, memory loss or dementia sufficient in severity to preclude informed consent or in the opinion of the investigator would prevent satisfactory completion of some or all of the testing.
- Any circumstance that in the opinion of the investigator, would interfere with participation in, or compliance with the study protocol
- Current pregnancy as reported by patient
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openVision Research and Assessment Institute
Irvine, California, United States
- Shawn Yu, OD · Contact949-264-3793info@vr-ai.com
Recruiting
Study team
Sponsor
Ray Therapeutics, Inc.
Study ID RTx-VRAI-NHS01
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.